Page 88 - அவசரம் பல்கலைக்கழகம் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Balancing Act: As pandemic pace slows, hospital chaplain sees COVID-19 workers begin to process trauma All of us up here were fighting a war
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
The police officer who fatally shot 13-year-old Adam Toledo was listed as a victim on an incident report One law enforcement expert said it s an old cop trick meant to muddy the murky waters
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
WOBURN, Mass., April 19, 2021 /PRNewswire/ Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a Bay Area-based private company developing groundbreaking therapies in endovascular embolization, announced that the first patient has been enrolled in the LAVA Study to evaluate the safety and effectiveness of the BlackSwan Lava™ liquid embolic system (LES) for the embolic treatment of arterial hemorrhage in the peripheral vasculature.
The LAVA Study, which stands for
Liquid Embolization of
Arterial Hemorrhages in Peripheral
Vasculature, is a prospective, multicenter single-arm study of 113 subjects at 20 investigational sites in the U.S. The first subject has been enrolled at the University of North Carolina School of Medicine in Chapel Hill, North Carolina, where a clinical team successfully treated a patient with a bleeding hypervascular tumor in the liver using
Overcoming isolation: Loneliness is rampant. A simple call, or hug, may be a cure
Lindsey Tanner and Martha Irvine Associated Press
April 17, 2021
FacebookTwitterEmail
1of9
Janine Blezien sits with her dogs, Kasey and Gordy. Blezien, who is single, said talking with retiree Dianne Green, through the Rush University Medical Center’s “friendly caller” program, also helped her feel less isolated last year. “We just clicked,” she said. Show MoreShow Less
2of9
Janine Blezien (left) and Dianne Green walk arm-in-arm at Rush University Medical Center in Chicago during their first in-person meeting. Blezien, a nurse at Rush, and Green, a retiree, met by phone the previous year through the hospital’s “friendly caller” program for which Blezien is a volunteer. They were able to get together after being vaccinated against COVID-19, and they plan to go out to a restaurant and shop together, once they both feel safe doing so. Show MoreShow Less
Scott Cohen of Plainview, N.Y., nearly died from the effects of Covid-19 and received convalescent plasma as part of his treatment. When he later recovered, he went on to donate his own plasma 11 times.Credit.Desiree Rios for The New York Times
Sections
The Covid-19 Plasma Boom Is Over. What Did We Learn From It?
The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled.
Scott Cohen of Plainview, N.Y., nearly died from the effects of Covid-19 and received convalescent plasma as part of his treatment. When he later recovered, he went on to donate his own plasma 11 times.Credit.Desiree Rios for The New York Times
vimarsana © 2020. All Rights Reserved.